시장보고서
상품코드
1596861

영양유전체학 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 용도별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)

Nutrigenomics Market Size, Share, Growth Analysis, By Product, By Technique, By Application, By End Use, By Region -Industry Forecast 2024-2031.

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 209 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 영양유전체학 시장 규모는 2022년 3억 8,620만 달러로 2023년 4억 5,379만 달러에서 2031년에는 16억 4,874만 달러로 성장할 것으로 예상되며, 예측 기간(2024-2031년) 동안 17.50%의 CAGR로 성장할 것으로 예상됩니다.

향후 몇 년 동안 세계 영양유전체학 시장은 만성질환의 유병률 증가를 주요 요인으로 성장세를 보일 것으로 예상됩니다. 지난 10년간 단백질체학, 유전체학, 대사체학의 발전으로 단백질 경로를 분석하여 질병을 식별하는 능력이 크게 향상되었으며, 특히 당뇨병, 암, 비만과 같은 식습관 선택에 영향을 받는 질병에 대한 분석 능력이 크게 향상되었습니다. 영양유전체학은 식품과 유전자 발현의 상호 작용을 탐구하여 다양한 식재료가 개인의 유전자 프로필을 어떻게 변화시키는지에 대한 인사이트를 제공합니다. 그러나 유전자 연구 및 검사를 둘러싼 정부 규제가 영양유전체학 제품 및 서비스의 시장 개척을 가로막고 있다는 문제도 제기되고 있습니다. 연방정부, 주정부 또는 지방정부가 시행하는 법규가 강화되면 유전자 검사가 더 까다로워져 임상 관리 및 연구에서의 채택에 영향을 미칠 수 있습니다. 또한, 소비자 직접 의뢰(DTC) 관련 법률이 지역별로 상이하다는 점도 상황을 더욱 복잡하게 만들고 있으며, 이는 영양유전체학 관련 기업들에게 큰 장벽으로 작용하고 있습니다. 결과적으로, 시장 확대의 잠재력이 큰 반면, 규제적 장애물은 혁신적인 영양유전체학 검사 솔루션을 소비자에게 제공하고자 하는 기업들에게 중요한 고려사항이 될 것으로 보입니다.

목차

소개

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 가정과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porters 분석과 영향
    • 경쟁 기업 간의 경쟁 관계
    • 대체품의 위협
    • 구매자의 교섭력
    • 신규 참여업체의 위협
    • 공급 기업의 교섭력

주요 시장 인사이트

  • 주요 성공요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 기술의 진보
  • 규제 상황
  • 사례 연구 분석
  • PESTEL 분석
  • 시장 매력 지수
  • 가격 분석

세계의 영양유전체학 시장 규모 : 제품별·CAGR(2024-2031년)

  • 시장 개요
  • 시약·키트
  • 서비스

세계의 영양유전체학 시장 규모 : 기술별·CAGR(2024-2031년)

  • 시장 개요
  • 타액
  • 볼점막 스왑
  • 혈액

세계의 영양유전체학 시장 규모 : 용도별·CAGR(2024-2031년)

  • 시장 개요
  • 비만
  • 심혈관질환
  • 암 조사
  • 기타

세계의 영양유전체학 시장 규모 : 최종 용도별·CAGR(2024-2031년)

  • 시장 개요
  • 병원·클리닉
  • 온라인 플랫폼
  • 기타

세계의 영양유전체학 시장 규모·CAGR(2024-2031년)

  • 북미(제품, 기법, 용도, 최종 용도)
    • 미국
    • 캐나다
  • 유럽(제품, 기법, 용도, 최종 용도)
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타 유럽
  • 아시아태평양(제품, 기법, 용도, 최종 용도)
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카(제품, 기법, 용도, 최종 용도)
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카(제품, 기법, 용도, 최종 용도)
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사의 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채용한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2023년)
  • 주요 기업 개요
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출 전년비 비교(2021-2023년)

주요 기업 개요

  • Nutrigenomix
  • The Gene Box
  • Metagenics
  • Xcode Life
  • GX Sciences, LLC(Fagron)
  • Cura Integrative Medicine
  • DNAlife
  • Genova Diagnostics(GDX)
  • Holistic Health International, Llc
  • Vitagene
  • Mapmygenome
  • GeneOmbio
  • 23andMe Inc.
  • DNAfit
  • GX Sciences Inc.
  • Amway
  • Herbalife Nutrition Ltd.
  • DSM Nutritional Products
  • Syngene International

결론과 제안

ksm 24.11.29

Global Nutrigenomics Market size was valued at USD 386.20 million in 2022 and is poised to grow from USD 453.79 million in 2023 to USD 1648.74 million by 2031, growing at a CAGR of 17.50% during the forecast period (2024-2031).

In the coming years, the global nutrigenomics market is poised for growth, largely driven by the rising prevalence of chronic illnesses. The advancements in proteomics, genomics, and metabolomics over the past decade have significantly enhanced the ability to identify diseases by analyzing protein pathways, especially in conditions like diabetes, cancer, and obesity, which are influenced by dietary choices. Nutrigenomics explores the interplay between food and gene expression, offering insights into how various dietary components can modify an individual's genetic profile. However, the market faces challenges from government regulations surrounding genetic research and testing, which can hamper the development of nutrigenomics products and services. Stricter laws imposed by federal, state, or local authorities can make genetic testing more cumbersome, affecting its adoption in clinical management and research. Additionally, the inconsistency of legislation related to direct-to-consumer (DTC) testing in different regions further complicates the landscape, creating a significant barrier for companies engaged in nutrigenomics. As a result, while there is substantial potential for market expansion, regulatory hurdles will be an important factor to consider for businesses aiming to innovate and bring nutrigenomics testing solutions to consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutrigenomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutrigenomics Market Segmental Analysis

Global Nutrigenomics Market is segmented into Product, Technique, Application, End Use, and region. By Product, the market is classified into Reagents & Kits, and Services. Depending on the Technique, it is categorized into Saliva, Buccal Swab, Blood. According to Application, the market is divided into Obesity, Cardiovascular Diseases, Cancer Research, Other. Based on End Use, the market is segmented into Hospitals & Clinics, Online Platforms, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Nutrigenomics Market

The global nutrigenomics market is witnessing significant growth driven by the escalating prevalence of chronic diseases, such as obesity, diabetes, and cardiovascular conditions. As these health issues become more prevalent, there is a growing demand for personalized nutrition that takes individual genetic factors into account. This customization of dietary approaches not only aids in the prevention and management of these ailments but also stimulates increased investments in tailored nutrition strategies. Consequently, the focus on nutrigenomics, which integrates genetic insights into dietary planning, is propelling market expansion and offering innovative solutions for better health outcomes globally.

Restraints in the Global Nutrigenomics Market

The global nutrigenomics market encounters significant challenges due to limited scientific evidence supporting the effectiveness of personalized nutrition interventions. While research in this area has shown potential, there remains a lack of extensive clinical validation and large-scale studies that demonstrate the long-term benefits of these solutions. Consequently, this uncertainty leads to skepticism among health care professionals and hesitance among consumers, ultimately impacting the overall acceptability and adoption of nutrigenomic solutions. The absence of robust data to substantiate claims about personalized nutrition hampers the market's growth and poses a considerable restraint on its development on a global scale.

Market Trends of the Global Nutrigenomics Market

The global nutrigenomics market is experiencing a significant trend towards personalized nutrition, driven by advancements in genetic testing and data analytics. Consumers are increasingly seeking tailored dietary solutions that align with their unique genetic profiles, which results in optimized health outcomes and preventive care. This surge is further amplified by the growing awareness of the relationship between genes, diet, and health, alongside increasing consumer demand for personalized health interventions. As companies innovate to offer customized nutritional plans, the market is poised for robust growth, with a wide range of applications in personal health management, chronic disease prevention, and overall wellness enhancement.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Case Study Analysis
  • PESTEL Analysis
  • Market Attractiveness Index
  • Pricing Analysis

Global Nutrigenomics Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Reagents & Kits
  • Services

Global Nutrigenomics Market Size by Technique & CAGR (2024-2031)

  • Market Overview
  • Saliva
  • Buccal Swab
  • Blood

Global Nutrigenomics Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Obesity
  • Cardiovascular Diseases
  • Cancer Research
  • Others

Global Nutrigenomics Market Size by End Use & CAGR (2024-2031)

  • Market Overview
  • Hospitals & Clinics
  • Online Platforms
  • Others

Global Nutrigenomics Market Size & CAGR (2024-2031)

  • North America, (Product, Technique, Application, End Use)
    • US
    • Canada
  • Europe, (Product, Technique, Application, End Use)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product, Technique, Application, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product, Technique, Application, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product, Technique, Application, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Nutrigenomix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Gene Box
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metagenics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xcode Life
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GX Sciences, LLC (Fagron)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cura Integrative Medicine
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DNAlife
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genova Diagnostics (GDX)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Holistic Health International, Llc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitagene
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mapmygenome
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeneOmbio
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 23andMe Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DNAfit
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GX Sciences Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amway
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Herbalife Nutrition Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DSM Nutritional Products
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syngene International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제